Wedbush Initiates Coverage On National Health Investors with Neutral Rating, Announces Price Target of $54
Portfolio Pulse from Benzinga Newsdesk
Wedbush analyst Richard Anderson has initiated coverage on National Health Investors (NYSE:NHI) with a Neutral rating. He also announced a price target of $54 for the company's stock.
October 03, 2023 | 11:58 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
National Health Investors has been given a Neutral rating by Wedbush, with a price target of $54. This could influence investor sentiment and potentially impact the stock's price.
The Neutral rating from Wedbush indicates that the analyst believes the stock will perform in line with the market average. This could maintain the current investor sentiment and not significantly drive the stock price up or down. However, the price target of $54 could influence investor expectations and potentially impact the stock's price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100